Catalyst Awardee

Project Description

TCM program for cancer pain prevention and treatment

Li Feng, MD, PhD, Lixing Liu, MD, PhD, Jiayang Chen, MD, PhD, Yukun Yin, MD, PhD, Yurong Zhang, MD, Zishu Qin, MD, Zhenglong Jiang, MD, Wei Jin, MD, PhD, Jie Li, MD, PhD, Qinglin Zhang, MD, PhD, Jinyuan Chang, MD, Peijin Li, MD, Hao Li, MD |  National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.
Competition Sponsor: Chinese Academy of Medical Sciences
Awardee Year: 2020

Malignant tumors and cancer pain are serious health problems that occur with the aging of the population, which have a bad impact on people’s lives as well as health and social and economic development. In recent years, with the increasing recognition of malignant tumors and other chronic diseases, traditional Chinese medicine has gradually become a new opportunity for research and treatment of malignant tumors and cancer pain. This research uses the platform of the National Cancer Center/National Cancer Research Center to take cancer pain patients as an example. It has a patented Chinese medicine preparation Yishen Qutong Granule with perfect medicinal properties, pharmacodynamics, clinical efficacy and safety evaluation. The method of strengthening vitality, removing blood stasis and detoxification with granules as the core drug is the principle of treatment, using multi-center, triple-blind, randomized controlled clinical trial research methods, combined with the team’s concept of “cancer pain TCM treatment superior population” for data processing, and finally formed A standardized treatment plan for traditional Chinese medicine to treat cancer pain promoted to primary medical institutions to achieve the goal of taking the lead in action and promoting people’s health.


View this project poster, first displayed at the 2021 Global Innovator Summit.


Sign up for updates